Managing the transition to secondary progressive multiple sclerosis: a scoping review

被引:0
|
作者
Giordano, Andrea [1 ]
Koepke, Sascha [2 ]
Confalonieri, Paolo [3 ]
Onofrj, Marco [4 ]
Pietrolongo, Erika [4 ]
Trojano, Maria [5 ,6 ,7 ]
Tortorella, Carla [5 ,6 ,7 ]
Borreani, Claudia [8 ]
Uccelli, Michele Messmer [9 ]
Gitto, Lara [10 ]
Giovannetti, Ambra Mara [3 ]
Solari, Alessandra [1 ]
机构
[1] Fdn IRCCS Neurol Inst C Besta, Unit Neuroepidemiol, Milan, Italy
[2] Univ Lubeck, Inst Social Med & Epidemiol, Lubeck, Germany
[3] Fdn IRCCS Neurol Inst C Besta, Dept Neuroimmunol & Neuromuscular Dis, Milan, Italy
[4] G Dannunzio Univ Chieti Pescara, Dept Neurosci Imaging & Clin Sci, Chieti, Italy
[5] Univ Bari, Dept Basic Med Sci, Bari, Italy
[6] Univ Bari, Dept Neurosci, Bari, Italy
[7] Univ Bari, Dept Sense Organs, Bari, Italy
[8] Fdn IRCCS Ist Nazl Cura Tumori, Unit Clin Psychol, Milan, Italy
[9] Italian Multiple Sclerosis Assoc, Dept Hlth Serv & Res, Genoa, Italy
[10] Tor Vergata Univ Rome, Fac Econ, CEIS, Rome, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:912 / 913
页数:2
相关论文
共 50 条
  • [41] Parkinsonism secondary to primary progressive multiple sclerosis
    Gallardo, M.
    Soto, A.
    MOVEMENT DISORDERS, 2010, 25 (07) : S498 - S498
  • [42] Siponimod for the treatment of secondary progressive multiple sclerosis
    Dumitrescu, Laura
    Constantinescu, Cris S.
    Tanasescu, Radu
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 143 - 150
  • [43] Secondary Progressive Multiple Sclerosis: Definition and Measurement
    Domenico Plantone
    Floriana De Angelis
    Anisha Doshi
    Jeremy Chataway
    CNS Drugs, 2016, 30 : 517 - 526
  • [44] Siponimod to treat secondary progressive multiple sclerosis
    Gajofatto, A.
    Turatti, M.
    DRUGS OF TODAY, 2020, 56 (01) : 37 - 46
  • [45] Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview
    Floriana De Angelis
    Domenico Plantone
    Jeremy Chataway
    CNS Drugs, 2018, 32 : 499 - 526
  • [46] Fatigue and motivation in secondary progressive multiple sclerosis
    Tacchino, A.
    Ponzio, M.
    Podda, J.
    Pedulla, L.
    Crivelli, D.
    Battaglia, M. A.
    Bove, M.
    Brichetto, G.
    Balconi, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 635 - 635
  • [47] Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview
    De Angelis, Floriana
    Plantone, Domenico
    Chataway, Jeremy
    CNS DRUGS, 2018, 32 (06) : 499 - 526
  • [48] MRI Activity in Secondary Progressive Multiple Sclerosis
    Zohar, Daniela Noa
    Achiron, Anat
    NEUROLOGY, 2020, 94 (15)
  • [49] MRI aspects of secondary progressive multiple sclerosis
    Wolinsky, JS
    MULTIPLE SCLEROSIS, 2002, 8 (01): : 85 - 87
  • [50] Siponimod for active secondary progressive multiple sclerosis
    Gaber, Tarek
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2021, 25 (02) : 4 - 5